CN111544560A - 一种治疗湿疹的中药组合物 - Google Patents
一种治疗湿疹的中药组合物 Download PDFInfo
- Publication number
- CN111544560A CN111544560A CN202010509259.4A CN202010509259A CN111544560A CN 111544560 A CN111544560 A CN 111544560A CN 202010509259 A CN202010509259 A CN 202010509259A CN 111544560 A CN111544560 A CN 111544560A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- root
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 31
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 210000000582 semen Anatomy 0.000 claims abstract description 12
- 241000885743 Melastoma dodecandrum Species 0.000 claims abstract description 11
- 229940126680 traditional chinese medicines Drugs 0.000 claims abstract description 11
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 10
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 10
- 240000006927 Foeniculum vulgare Species 0.000 claims abstract description 10
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims abstract description 10
- 235000008694 Humulus lupulus Nutrition 0.000 claims abstract description 10
- 240000007849 Macleaya cordata Species 0.000 claims abstract description 10
- 244000126014 Valeriana officinalis Species 0.000 claims abstract description 10
- 235000013832 Valeriana officinalis Nutrition 0.000 claims abstract description 10
- 229940116229 borneol Drugs 0.000 claims abstract description 10
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 10
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000016788 valerian Nutrition 0.000 claims abstract description 10
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims abstract description 9
- 244000213382 Nymphaea lotus Species 0.000 claims abstract description 9
- 235000010710 Nymphaea lotus Nutrition 0.000 claims abstract description 9
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims abstract description 9
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims abstract description 9
- 239000010440 gypsum Substances 0.000 claims abstract description 9
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 9
- 239000010446 mirabilite Substances 0.000 claims abstract description 9
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241000471262 Ardisia japonica Species 0.000 claims abstract description 8
- 241001061264 Astragalus Species 0.000 claims abstract description 8
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 claims abstract description 8
- 244000224182 Gomphrena globosa Species 0.000 claims abstract description 8
- 241001643425 Tinospora sinensis Species 0.000 claims abstract description 8
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 8
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 8
- 235000006533 astragalus Nutrition 0.000 claims abstract description 8
- 235000008397 ginger Nutrition 0.000 claims abstract description 8
- 241000723289 Dianella <angiosperm> Species 0.000 claims abstract description 5
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 5
- 244000037185 Cinnamomum burmannii Species 0.000 claims abstract description 4
- 235000014487 Cinnamomum burmannii Nutrition 0.000 claims abstract description 4
- 244000301850 Cupressus sempervirens Species 0.000 claims abstract description 4
- 244000055664 Dichroa febrifuga Species 0.000 claims abstract description 4
- 244000088415 Raphanus sativus Species 0.000 claims abstract description 4
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 4
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 4
- 244000007853 Sarothamnus scoparius Species 0.000 claims abstract description 4
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract 2
- 244000058946 Dianella ensifolia Species 0.000 claims description 5
- 241001643730 Hydrangea sect. Dichroa Species 0.000 claims description 5
- 240000004980 Rheum officinale Species 0.000 claims description 5
- 235000008081 Rheum officinale Nutrition 0.000 claims description 5
- 230000000410 anti-febrile effect Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 18
- 239000000463 material Substances 0.000 abstract description 7
- 239000000843 powder Substances 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 229940099259 vaseline Drugs 0.000 abstract description 6
- 238000000227 grinding Methods 0.000 abstract description 5
- 230000007774 longterm Effects 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 abstract description 5
- 238000004806 packaging method and process Methods 0.000 abstract description 5
- 238000003756 stirring Methods 0.000 abstract description 5
- 230000007794 irritation Effects 0.000 abstract description 3
- 239000002674 ointment Substances 0.000 description 18
- 210000003491 skin Anatomy 0.000 description 9
- 208000003251 Pruritus Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000007480 spreading Effects 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 4
- 230000003187 abdominal effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 206010040882 skin lesion Diseases 0.000 description 4
- 231100000444 skin lesion Toxicity 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 208000010201 Exanthema Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 231100000167 toxic agent Toxicity 0.000 description 3
- 238000011725 BALB/c mouse Methods 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 241000219061 Rheum Species 0.000 description 2
- 241000915604 Scutellaria barbata Species 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 239000002955 immunomodulating agent Substances 0.000 description 2
- 229940121354 immunomodulator Drugs 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000004377 improving vision Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000019508 mustard seed Nutrition 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 240000006248 Broussonetia kazinoki Species 0.000 description 1
- 206010012435 Dermatitis and eczema Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000428813 Gomphrena Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010027940 Mood altered Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 241000220261 Sinapis Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000002029 allergic contact dermatitis Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000008338 calamine lotion Substances 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940124589 immunosuppressive drug Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 230000007510 mood change Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- KASDHRXLYQOAKZ-ZPSXYTITSA-N pimecrolimus Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C/C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](Cl)[C@H](OC)C1 KASDHRXLYQOAKZ-ZPSXYTITSA-N 0.000 description 1
- 229960005330 pimecrolimus Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 229960001967 tacrolimus Drugs 0.000 description 1
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940124024 weight reducing agent Drugs 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗湿疹的中药组合物,由下列重量份数的中药制成:大黄10‑30份、地肤子10‑30份、蛇麻10‑30份、地骨皮10‑30份、白莲10‑30份、松香10‑30份、煅石膏10‑30份、芒硝10‑30份、冰片10‑30份、宽筋藤5‑15份、博落回5‑15份、山菅兰5‑15份、半枝莲5‑15份、常山2‑8份、苍术2‑8份、千日红2‑8份、地菍根2‑8份、缬草2‑8份、沙苑子2‑8份、楮实子1‑3份、干姜1‑3份、矮地茶1‑3份、茴香根1‑3份、莱菔子1‑3份、石菖蒲1‑3份、芥子1‑3份、阴香根1‑3份。以上中药研成粉末,将粉末与医用凡士林混合,搅拌成膏状分装即可。本发明中药组合物组方科学,不仅针对性强、治愈率高、复发率低,刺激性小,而且长期使用无任何的毒副作用。
Description
技术领域
本发明涉及中药技术领域,具体是涉及一种治疗湿疹的中药组合物。
背景技术
湿疹是复杂的内外因子引起的一种迟发型变态反应,好发于头面、四肢屈侧及会阴等部位,常呈泛发或对称性分布。湿疹病因复杂,常为内外因相互作用结果。内因如慢性消化系统疾病、精神紧张、失眠、过度疲劳、情绪变化、内分泌失调、感染、新陈代谢障碍等,外因如生活环境、气候变化、食物等均可影响湿疹的发生。外界刺激如日光、寒冷、干燥、炎热、热水烫洗以及各种动物皮毛、植物、化妆品、肥皂、人造纤维等均可诱发。湿疹分急性、亚急性、慢性三期。急性期以丘疱疹为主,具渗出倾向。慢性期以苔藓样变为主,浸润、肥厚。湿疹易反复发作,皮损具有多形性、对称性、瘙痒和易反复发作等特点。
湿疹很常见,尤其是对于一岁以下的婴儿。不管任何时候,无论身体的哪一个部位患了皮炎湿疹,都会因为因剧烈的瘙痒给患者带来较大的痛苦,甚至影响其正常的工作、生活,如果长期的复发会导致患者精神萎靡,烦躁及出现其它一些精神因素障碍。因此必须对它进行积极有效的治疗。
针对湿疹的治疗,分为内用疗法和外用疗法。湿疹的内用疗法以内服激素为主,主要的口服药物有抗肿瘤及免疫抑制药、免疫调节剂、肾上腺糖皮质激素类药物、细胞抑制剂、还原剂、抗生素以及角质剥脱剂等。外用药物有糖皮质激素霜剂、焦油类制剂、炉甘石洗剂、硼酸或高锰酸钾溶液、免疫调节剂如他克莫司软膏、匹美莫司软膏等。采用这些药物治疗虽然在短时间内对皮损的消退效果非常显著,但是长期使用后,不仅患者会对药物产生依赖,一旦停药,病情就会立即复发,增加后期的治疗难度,而且价格昂贵,毒副作用大,长期使用会导致皮肤老化或癌化,长期服用对肝功、肾功、造血系统等都有不同程度的损伤。
中医学方面,用于治疗治疗湿疹的中药外用药的也比较多,如湿疹膏、湿毒膏、普连软膏、五石膏等,虽然毒副作用小,但药效不甚理想。因此,研制开发一种疗效好、大面积使用无刺激性、毒副作用小、使用方面、既能提高患者的顺应性、又能减少给药次数的治疗湿疹的中药外用制剂是客观需要的。
发明内容
本发明的目的是解决现有技术的不足,提供一种高效、安全地的治疗湿疹的中药组合物。本发明组方在现有技术的基础上,查阅大量文献,通过大量实验,筛选大黄、地肤子、蛇麻、地骨皮、白莲、松香、煅石膏、芒硝、冰片、宽筋藤、博落回、山菅兰、半枝莲、常山、苍术、千日红、地菍根、缬草、沙苑子、楮实子、干姜、矮地茶、茴香根、莱菔子、石菖蒲、芥子、阴香根,将以上中药按重量份数分别研成粉末后与医用凡士林混合,搅拌成膏状分装即成。使用时直接涂于患处,或者将软膏摊在纱布上敷于患处。大黄泻热毒,破积滞,行瘀血。地肤子清热利湿,祛风止痒。蛇麻健胃消食,化痰止咳,抗痨,安神利尿。地骨皮退热除蒸,凉血除蒸,清肺降火。白莲补脾益肾,养心安神。松香祛风燥湿,排脓拔毒,生肌止痛。煅石膏收湿,生肌,敛疮,止血。芒硝泻下通便,润燥软坚,清火消肿。冰片开窍醒神,清热散毒。宽筋藤舒筋活络,祛风止痛。博落回散瘀,祛风,解毒,止痛,杀虫。山菅兰拔毒消肿。半枝莲清热解毒,活血化瘀,消肿止痛。常山涌吐痰涎,截疟。苍术燥湿健脾,祛风散寒,明目。千日红,清肝明目,解毒。地菍根,活血,止血,利湿,解毒。缬草,安神镇静,驱风解痉,生肌止血,止痛。沙苑子补肾助阳,固精缩尿,养肝明目。楮实子滋肾益阴,清肝明目,利水消肿。干姜温中散寒,回阳通脉,温肺化饮。矮地茶化痰止咳,利湿,活血。茴香根温肾和中,行气止痛。莱菔子消食除胀,降气化痰。石菖蒲理气,活血,散风,去湿。芥子散结通络止痛。阴香根温中行气止痛。 全方是以中医药理论为基础进行的科学组方,而不是功效药味的简单组合,诸药协同组方,共同发挥清热、解毒、利湿、祛风、止痒、抗炎等功效,能通透润燥,畅通气血,温通经络,润泽皮肤等。
本发明是采用如下技术方案实现的:
一种治疗湿疹的中药组合物,由下列重量份数的中药制成:大黄10-30份、地肤子10-30份、蛇麻10-30份、地骨皮10-30份、白莲10-30份、松香10-30份、煅石膏10-30份、芒硝10-30份、冰片10-30份、宽筋藤5-15份、博落回5-15份、山菅兰5-15份、半枝莲5-15份、常山2-8份、苍术2-8份、千日红2-8份、地菍根2-8份、缬草2-8份、沙苑子2-8份、楮实子1-3份、干姜1-3份、矮地茶1-3份、茴香根1-3份、莱菔子1-3份、石菖蒲1-3份、芥子1-3份、阴香根1-3份。
优选的,一种治疗湿疹的中药组合物,由下列重量份数的中药制成:大黄20份、地肤子20份、蛇麻20份、地骨皮20份、白莲20份、松香20份、煅石膏20份、芒硝20份、冰片20份、宽筋藤10份、博落回10份、山菅兰10份、半枝莲10份、常山5份、苍术5份、千日红5份、地菍根5份、缬草5份、沙苑子5份、楮实子2份、干姜2份、矮地茶2份、茴香根2份、莱菔子2份、石菖蒲2份、芥子2份、阴香根2份。
一种治疗湿疹的中药组合物的制备方法:将以上中药,分别按重量份数研成粉末,与医用凡士林混合,搅拌成膏状,分装即可。使用时直接涂于患处,或者将软膏摊在纱布上敷于患处。
本发明中药组合物组方科学,不仅针对性强、治愈率高、复发率低,刺激性小,而且长期使用无毒副作用,不会产生抗药性和依赖性,能彻底的抑制湿疹发展,减少复发,改善患者的心理或社会生活质量,具有较好的推广利用价值。
具体实施方式
下面结合实施例对本发明作进一步的说明,但不以任何方式对本发明加以限制,基于本发明教导所作的任何变换或替换,均属于本发明的保护范围。
实施例1
一种治疗湿疹的中药组合物,由下列重量份数的中药制成:大黄20份、地肤子20份、蛇麻20份、地骨皮20份、白莲20份、松香20份、煅石膏20份、芒硝20份、冰片20份、宽筋藤10份、博落回10份、山菅兰10份、半枝莲10份、常山5份、苍术5份、千日红5份、地菍根5份、缬草5份、沙苑子5份、楮实子2份、干姜2份、矮地茶2份、茴香根2份、莱菔子2份、石菖蒲2份、芥子2份、阴香根2份。将以上中药,分别按重量份数研成粉末,与医用凡士林混合,搅拌成膏状,分装即可。使用时直接涂于患处,或者将软膏摊在纱布上敷于患处。
实施例2
一种治疗湿疹的中药组合物,由下列重量份数的中药制成:大黄30份、地肤子30份、蛇麻30份、地骨皮30份、白莲30份、松香30份、煅石膏30份、芒硝30份、冰片30份、宽筋藤5份、博落回5份、山菅兰5份、半枝莲5份、常山2份、苍术2份、千日红2份、地菍根2份、缬草2份、沙苑子2份、楮实子1份、干姜1份、矮地茶1份、茴香根1份、莱菔子1份、石菖蒲1份、芥子1份、阴香根1份。将以上中药,分别按重量份数研成粉末,与医用凡士林混合,搅拌成膏状,分装即可。使用时直接涂于患处,或者将软膏摊在纱布上敷于患处。
实施例3
一种治疗湿疹的中药组合物,由下列重量份数的中药制成:大黄10份、地肤子10份、蛇麻10份、地骨皮10份、白莲10份、松香10-30份、煅石膏10-30份、芒硝10-30份、冰片10份、宽筋藤5份、博落回5份、山菅兰5份、半枝莲5份、常山8份、苍术8份、千日红8份、地菍根8份、缬草8份、沙苑子8份、楮实子3份、干姜3份、矮地茶3份、茴香根3份、莱菔子3份、石菖蒲3份、芥子3份、阴香根3份。将以上中药,分别按重量份数研成粉末,与医用凡士林混合,搅拌成膏状,分装即可。使用时直接涂于患处,或者将软膏摊在纱布上敷于患处。
实施例4
动物试验:6-8周龄的健康雌性SPF级BALB/c小鼠30只,体重20-25g,实验室温度( 24±2)℃,相对湿度55%-65%,昼夜时间控制在各12小时,给予3天适应性喂养。以2,4-二硝基氯苯( DNCB) 诱导建立变应性接触性皮炎动物模型。实验前2日剃去小鼠腹部体毛,面积约2.5cm×2.5cm。实验第1天用2%DNCB丙酮溶液100μl涂于腹部剃毛处、四肢和耳部,实验第2-4天不作处理,第5天改用1% DNCB丙酮溶液100μl涂搽小鼠的腹部剃毛处和耳部。将造模成功的30只雌性BALB/c小鼠随机分为2组,其中空白组10只、实验组20只。从第6天开始,空白组不治疗,实验组给予本实施1的中药膏,1天3次,连续用药7天。观察病灶处恢复程度。
实验结果:空白组,小鼠腹部皮肤均在致敏第4天开始出现水肿、表皮增厚等改变,随着时间推移,症状逐渐加重,至第14天时,仍然存在表皮脱落、渗出、皮疹、苔藓样变等。而治疗组小鼠腹部皮肤红斑、皮疹、渗出、结痂等的皮炎症状随着用药逐渐减轻,在用本发明实施例1中药膏7天后,皮肤状态恢复至造模前。
实施例5
临床试验:统计记录在案并使用本发明实施例1中药膏治疗湿疹的患者共70例,其中男31例,女39例,年龄分布在0.5岁-60岁之间。统计使用本发明实施例1中药膏治疗后患者的皮肤状况。
实验结果:其中66例患者在使用本发明后,症状消失,湿疹得到根治,为显效,占94.3%;其中有4例患者在使用本发明后,症状缓解,瘙痒等得到明显改善,为有效,占5.7%。
临床治疗典型病例:
病例1:孙某某,女,8个月,2019年10月15日初诊。患儿自添加辅食后颜面部开始出现粟粒大小丘疹、水疱,基底潮红,部分融合成片,患儿搔抓后皮损处有点状渗出及小糜烂面,边缘不清,予“湿疹膏”外擦,可缓解,但停药后复发。给予本实施1的中药膏,1天3次,3天为1疗程。3天后复诊,皮损有所消退,皮肤潮红减轻,糜烂处愈合,渗出明显减少,有轻度脱屑,继用1个疗程巩固治疗,颜面部皮疹消失,皮肤光滑。随访半年未复发。
病例2:蔡某,女,25岁,双下肢湿疹3天。给予本实施1的中药膏,1天3次,5天为1疗程。用药10天痊愈。随访一年无复发。
病例3:张某某,男,61岁,背部湿疹半年余。背部弥漫性红斑、丘疹伴瘙痒,局部皮肤粗糙、肥厚,出现苔藓样变。给予本实施1的中药膏,1天3次,7天为1疗程。1疗程后显著改善,后继续应用2疗程,痊愈。随访一年无复发。
以上所述仅为本发明的较佳实施例而已,并不以本发明为限制,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进,均应包含在本发明的保护范围之内。
Claims (2)
1.一种治疗湿疹的中药组合物,其特征在于,由下列重量份数的中药制成:大黄10-30份、地肤子10-30份、蛇麻10-30份、地骨皮10-30份、白莲10-30份、松香10-30份、煅石膏10-30份、芒硝10-30份、冰片10-30份、宽筋藤5-15份、博落回5-15份、山菅兰5-15份、半枝莲5-15份、常山2-8份、苍术2-8份、千日红2-8份、地菍根2-8份、缬草2-8份、沙苑子2-8份、楮实子1-3份、干姜1-3份、矮地茶1-3份、茴香根1-3份、莱菔子1-3份、石菖蒲1-3份、芥子1-3份、阴香根1-3份。
2.根据权利要求1所述的一种治疗湿疹的中药组合物,其特征在于,一种治疗湿疹的中药组合物,由下列重量份数的中药制成:大黄20份、地肤子20份、蛇麻20份、地骨皮20份、白莲20份、松香20份、煅石膏20份、芒硝20份、冰片20份、宽筋藤10份、博落回10份、山菅兰10份、半枝莲10份、常山5份、苍术5份、千日红5份、地菍根5份、缬草5份、沙苑子5份、楮实子2份、干姜2份、矮地茶2份、茴香根2份、莱菔子2份、石菖蒲2份、芥子2份、阴香根2份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010509259.4A CN111544560A (zh) | 2020-06-07 | 2020-06-07 | 一种治疗湿疹的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010509259.4A CN111544560A (zh) | 2020-06-07 | 2020-06-07 | 一种治疗湿疹的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111544560A true CN111544560A (zh) | 2020-08-18 |
Family
ID=71999216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010509259.4A Pending CN111544560A (zh) | 2020-06-07 | 2020-06-07 | 一种治疗湿疹的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111544560A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105168579A (zh) * | 2015-10-01 | 2015-12-23 | 成都倍加特生物科技有限公司 | 一种可有效治疗肛周湿疹的外用中药液及制备方法 |
CN105343340A (zh) * | 2015-11-26 | 2016-02-24 | 姜义祥 | 一种治疗湿疹的乳膏及其制备方法 |
CN106728168A (zh) * | 2017-01-20 | 2017-05-31 | 张颖 | 一种治疗湿疹、银屑病的中药外用制剂及其制备方法 |
-
2020
- 2020-06-07 CN CN202010509259.4A patent/CN111544560A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105168579A (zh) * | 2015-10-01 | 2015-12-23 | 成都倍加特生物科技有限公司 | 一种可有效治疗肛周湿疹的外用中药液及制备方法 |
CN105343340A (zh) * | 2015-11-26 | 2016-02-24 | 姜义祥 | 一种治疗湿疹的乳膏及其制备方法 |
CN106728168A (zh) * | 2017-01-20 | 2017-05-31 | 张颖 | 一种治疗湿疹、银屑病的中药外用制剂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100574778C (zh) | 治疗痤疮的中药复方制剂 | |
CN106177408B (zh) | 一种皮肤抗过敏中药组合物、中药制剂、面膜、制备方法 | |
CN100493594C (zh) | 一种治疗胆囊炎、胆管炎、胆汁返流性胃炎的膏药 | |
CN101703732B (zh) | 一种治疗带状疱疹的中药膏及其制备方法 | |
CN104324338A (zh) | 一种褥疮用护理贴 | |
CN104547904A (zh) | 一种治疗褥疮的中药 | |
CN105056154A (zh) | 一种治疗风湿痹痛的中药复方凝胶分散型贴剂 | |
CN105497534A (zh) | 一种防治电力职工电烧伤和火烧伤的防护品 | |
CN111544560A (zh) | 一种治疗湿疹的中药组合物 | |
CN115444912A (zh) | 一种治疗痤疮的组合物及其制备方法 | |
CN103599234B (zh) | 防治伤口感染的中药药液及其制备方法 | |
CN108721442B (zh) | 治疗烧烫伤及尿布皮炎的中药组合物、制剂及其制备方法 | |
CN101940652B (zh) | 治疗牛皮癣、各种顽癣、瘙痒症的中药擦剂 | |
CN104623554A (zh) | 用于改善下肢切口愈合情况的祛腐生肌散 | |
CN104800427A (zh) | 一种烧烫伤康复敷剂及其制备方法 | |
CN116942740B (zh) | 一种治疗腰椎间盘突出症的中药组合物及其应用 | |
CN115887601B (zh) | 一种用于痔疮的组合物及其制备方法 | |
CN102920800A (zh) | 一种外用药物组合物及其应用和制备方法 | |
CN1069038C (zh) | 跌打万应膏及其制备方法 | |
CN102920840A (zh) | 一种治疗痔疮的中药制剂 | |
CN101559185A (zh) | 一种治疗下肢静脉曲张的外用药物 | |
CN113842432A (zh) | 一种调理皮肤过敏瘙痒的外用膏剂及制备方法 | |
CN112439006A (zh) | 一种治疗顽固性神经性皮炎的中药组合物、酊剂及其制备方法 | |
CN120241893A (zh) | 一种治疗各类鼻炎的中药外用膏剂及其制备方法 | |
CN116474068A (zh) | 一种双效膏药贴 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200818 |
|
WD01 | Invention patent application deemed withdrawn after publication |